Astronics Corp. (ATRO) is the issuer in an amended ownership report from Dimensional Fund Advisors, which lists 335,448 shares, or 3.1% of the class, as beneficially owned as of September 30, 2026. The adviser reported sole voting power over 326,978 shares and sole dispositive power over 335,448 shares; shared voting and dispositive power were 0. The report states that the Funds own all reported securities and that Dimensional disclaims beneficial ownership.
Astronics Corp (ATRO) reported that James Mulato, Pres Astronics Test Systems, acquired 555 common shares and 111 Class B shares on September 30, 2026, at $31.85 per share through an Employee Stock Purchase Plan subscription agreement. Direct holdings afterward were 36,332 common shares and 10,209 Class B shares; no Rule 10b5-1 plan is reported. A listed option covers 6,560 common shares at a $26.47 exercise price and expires December 14, 2026. Restricted stock unit vesting is tied to average annual adjusted EBITDA.
Nancy L. Hedges, Astronics Corp.'s Principal Accounting Officer, acquired 555 common shares and 111 Class B shares on September 30, 2026, through exercise of a subscription agreement under the Employee Stock Purchase Plan, at $31.85 per share. Her reported direct holdings afterward were 32,604 common shares and 8,064 Class B shares.
She also reported target restricted stock units tied to average annual adjusted EBITDA, with 50% to 150% of target potentially vesting on scheduled dates in 2027, 2028 and 2029.
Astronics Corp. Secretary Julie M. Davis acquired 130 common shares and 26 Class B shares on September 30, 2026, with a reported price of $31.85 per share, through exercise of a subscription agreement under the Employee Stock Purchase Plan. No Rule 10b5-1 plan is reported. Her direct holdings after the acquisitions were 7,596 common shares and 2,282 Class B shares.
She also reported options covering 1,500 common shares and 926 Class B shares, each with a $26.47 exercise price and expiring December 14, 2026. Restricted stock units include 2,500 common and 500 Class B units scheduled to vest 100% on February 22, 2027, and 4,500 common and 900 Class B units scheduled to vest 100% on February 27, 2028. Performance-based target units cover 1,916 common and 383 Class B shares; between 50% and 150% of target may vest February 19, 2029, based on Astronics Corp.'s average annual adjusted EBITDA for January 1, 2026 through December 31, 2028.
Astronics Corp. (ATRO) Executive VP & Pres-Aerospace Mark Peabody acquired 555 common shares and 111 Class B shares on September 30, 2026, at $31.85 per share through exercise of a subscription agreement under the Employee Stock Purchase Plan. After the acquisitions, his direct holdings were 62,788 common shares and 232,721 Class B shares. No Rule 10b5-1 plan is reported.
ASTRONICS CORP (ATRO) director Jeffry D. Frisby exercised stock options on September 16, 2026 to acquire 4,000 shares of $.01 par value common stock and 1,520 shares of $.01 par value Class B stock at an exercise price of $23.75 per share. These shares were acquired upon option exercise, and following the transactions he held 49,056 common shares and 10,931 Class B shares directly. He also retained unexercised options tied to 4,000 common and 1,520 Class B shares at a strike price of $28.37 expiring March 2, 2028, and no Rule 10b5-1 trading plan is reported.
ASTRONICS CORP (ATRO) director Robert S. Keane reported an internal share reclassification on August 25, 2026. Boston & Saranac LLC, an entity indirectly associated with him, converted 76,000 Class B shares into 76,000 shares of $.01 par value common stock, all held indirectly. Keane also reports direct holdings of 13,934 common shares and 2,786 Class B shares, plus an additional indirect Class B position held in a trust where he is one of multiple beneficiaries with a proportionate interest below 25%.
Astronics Corp (ATRO) reported that Executive VP & President–Aerospace Mark Peabody made a bona fide gift of 150 shares of $.01 par value common stock on 2026-08-18, leaving him with 62,232.73 common shares held directly. He also directly holds 232,610 Class B shares and multiple stock options on both common and Class B stock at exercise prices between $8.12 and $29.68 per share. In addition, he holds several performance-based restricted stock unit awards, including 15,900, 15,150 and 7,675 common-stock RSUs (and corresponding Class B RSUs) that may vest between 50% and 150% of target based on Astronics’ average annual adjusted EBITDA over three-year periods ending in 2026, 2027 and 2028.
ASTRONICS CORP (ATRO) director Jeffry D. Frisby reported a bona fide gift of 2,000 shares of $.01 par value common stock on 2026-08-17, leaving him with 45,056 common shares held directly. He also holds 9,411 shares of $.01 par value Class B stock directly as of the same date.
In addition, Frisby continues to hold several option awards directly, including options over 4,000 common shares at $23.75 and 4,000 common shares at $28.37, plus options over 1,520 Class B shares at each of those exercise prices, with expirations in 2027 and 2028.
American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research report passive ownership in Astronics Corporation common stock. As of 06/30/2026, they collectively report beneficial ownership of 1,436,706 shares, representing 4.5% of the outstanding common stock.
The group reports sole voting power over 1,209,469 shares and sole dispositive power over 1,436,706 shares, with no shared voting or dispositive power. The filing is submitted jointly, with American Century Investment Management, Inc. acting as investment adviser and a wholly owned subsidiary of American Century Companies, Inc., which is controlled by the Stowers Institute for Medical Research.